Compare DV & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DV | PAHC |
|---|---|---|
| Founded | 2008 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.4B |
| IPO Year | 2021 | 2014 |
| Metric | DV | PAHC |
|---|---|---|
| Price | $13.55 | $39.06 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 15 | 4 |
| Target Price | $13.48 | ★ $44.00 |
| AVG Volume (30 Days) | ★ 1.8M | 201.9K |
| Earning Date | 11-06-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 1.21% |
| EPS Growth | N/A | ★ 104.20 |
| EPS | 0.12 | ★ 2.43 |
| Revenue | $748,291,000.00 | ★ $833,350,000.00 |
| Revenue This Year | $7.78 | $3.87 |
| Revenue Next Year | $8.34 | $3.56 |
| P/E Ratio | $112.92 | ★ $16.43 |
| Revenue Growth | ★ 13.92 | 4.12 |
| 52 Week Low | $7.61 | $28.25 |
| 52 Week High | $13.65 | $60.08 |
| Indicator | DV | PAHC |
|---|---|---|
| Relative Strength Index (RSI) | 62.66 | 59.27 |
| Support Level | $13.32 | $38.29 |
| Resistance Level | $13.56 | $40.65 |
| Average True Range (ATR) | 0.03 | 1.45 |
| MACD | -0.01 | 0.18 |
| Stochastic Oscillator | 75.00 | 61.36 |
DoubleVerify Holdings Inc is a media effectiveness platform that leverages artificial intelligence (AI) to drive superior outcomes for international brands by creating transparent ad transactions. Its solutions provide unbiased data analytics to improve the effectiveness, quality and return on advertising investments. DV Authentic Ad is its proprietary metric measuring whether an ad was delivered in a brand suitable environment, fully viewable, by a real person and in geography, while DV Pinnacle delivers these metrics in real time. The Company's solutions are integrated across programmatic platforms, social media channels and digital publishers, and are accredited by the Media Rating Council for digital ad measurement. It operates in the United States and international markets.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.